168 related articles for article (PubMed ID: 7053211)
1. In vitro demonstration of in situ autologous tumour-cell cytotoxicity in MSV-induced tumours in A/SN mice.
Becker S; Haskill S
Br J Cancer; 1981 Mar; 43(3):284-93. PubMed ID: 7053211
[TBL] [Abstract][Full Text] [Related]
2. Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells.
Weiland F; Weiland E; Mussgay M
Br J Cancer; 1979 Dec; 40(6):932-42. PubMed ID: 230854
[TBL] [Abstract][Full Text] [Related]
3. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
[TBL] [Abstract][Full Text] [Related]
4. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
5. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
Plata F; MacDonald HR; Shain B
J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765
[TBL] [Abstract][Full Text] [Related]
6. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
[TBL] [Abstract][Full Text] [Related]
7. Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.
Cerundolo V; Zanovello P; McIntosh D; Fabbris R; Davies AJ; Collavo D
Br J Cancer; 1987 Apr; 55(4):413-9. PubMed ID: 2437947
[TBL] [Abstract][Full Text] [Related]
8. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
Becker S; Haskill S
J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
[TBL] [Abstract][Full Text] [Related]
10. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
Plata F; Cerottini JC; Brunner KT
Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
[TBL] [Abstract][Full Text] [Related]
11. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
Jones DB; Moore M
Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).
Jones DB; Moore M
Br J Cancer; 1973 Jun; 27(6):415-26. PubMed ID: 4516007
[TBL] [Abstract][Full Text] [Related]
13. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
[TBL] [Abstract][Full Text] [Related]
14. Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.
Weiland E; Mussgay M
Arch Virol; 1980; 66(1):1-10. PubMed ID: 7436738
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of murine sarcoma virus-superinfected mouse tumor cells against outgrowth of corresponding noninfected tumor.
Kuzumaki N; Fenyö EM; Klein E; Klein G
Transplantation; 1978 Nov; 26(5):304-7. PubMed ID: 705875
[TBL] [Abstract][Full Text] [Related]
16. Defective cytotoxic T-cell generation in Moloney murine sarcoma virus-infected A/Sn mice.
Becker S; Klein E
J Natl Cancer Inst; 1980 Oct; 65(4):811-6. PubMed ID: 6968372
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
Wood GW
Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
Ryser JE; Cerottini JC; Brunner KT
Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
[TBL] [Abstract][Full Text] [Related]
19. Detection of cytotoxic lymphoid spleen cells from STU-mice with Moloney sarcoma by a 3H-proline microcytotoxicity assay.
Weiland E; Mussgay M
Med Microbiol Immunol; 1976 Jun; 162(2):81-7. PubMed ID: 1084460
[TBL] [Abstract][Full Text] [Related]
20. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
